Cervical cancer kills an estimated 275,000 women every year, 85 percent of whom are in developing countries. The link between HIV and cervical cancer is direct and deadly; HIV-infected women who are also infected with specific types of human papilloma virus (HPV) are 4-5 times more susceptible to cervical cancer than HIV-negative women.
Arogya World Archives
Re-electing a U.S. president and promoting a health behavior: What do these have in common?
Arogya World’s work to change the course of non-communicable diseases embraces sound science and effective strategies to realize behavior change. We are pleased to present this post by by Ann Jimerson, Senior Specialist in Behavior Change at Alive & Thrive, FHI 360.
President Joyce Banda: New Focus on Women’s Health and Empowerment in Malawi
We know that women’s health and empowerment are the key to global health and development, as well as a cornerstone in the fight against NCDs. This blog post and video by Janet Fleischman and Julia Nagel of CSIS underscores this connection.
NCDs and Development: Is Aid the Right Solution?
In countries whose health systems do rely heavily on aid, more disease-specific aid is not the answer – they need more fundamental support to establish a functioning health system, focused on training health workers, primary care, basic surveillance and access to medicines.
The Ball’s in Our Court: Part I Story of a Stage I Testicular Cancer Survivor
In honor of Movember and to advocate for testicular cancer prevention, Arogya World Fellow, Nikhil Patil, shares his own story of cancer survivorship. “Movember” is a global advocacy month where men grow mustaches to educate others about important men’s health issues.
Arogya World Launches Healthy Workplace Program in India
In a pioneering public health effort, Arogya World, a US-based non-profit organization with a domestic presence in Bangalore, today unveiled new Healthy Workplace Criteria as the first step of its Healthy Workplace program. Jointly developed by Arogya World and the Public Health Foundation of India (PHFI), after intense deliberations and prior multi-stakeholder consultations with the IT sector, allied organizations and medical experts at a Bangalore workshop organized by Arogya World in February 2012 – these criteria will promote workplace wellness, help reduce the burden of Non-Communicable Diseases (NCDs), and offer companies a competitive edge via increased talent retention and higher productivity.
Twitter & Facebook & YouTube, Oh My! 4 Lessons from the Social Good Summit 2012
This post originally appeared on Armchair Advocates. By Nikhil D.Patil, Arogya World Fellow Two weeks ago, New York was the place to be. While world leaders headed to the U.N…. Read More
A Country Perspective on the One Year Anniversary of the UN NCD Summit
Here in Uganda, health professionals have been leading from the frontlines and working tirelessly to improve the lives of those affected by NCDs. The UN Summit was a historical event and we know change will not come overnight, but we cannot wait any longer to take action. Now is the time to use the momentum from the Summit to focus on country action and scale up successful programmes. We invite you to join us and help make Uganda and other countries the next success story in the fight against NCDs.
What’s a Non-Communicable Disease and Why do I Care?
By 2030, non-communicable diseases will cause five times as many deaths as HIV/AIDS, TB, and Malaria COMBINED. With numbers so staggering how could I not have known? But learning what NCDs are was only the beginning of my journey. As a communications intern for Arogya World, I began to delve into the research trying to piece together the implications of NCDs. And what I learned is troublesome.
NCD Case Studies: “Best buys” for combating non-communicable disease
Over the past year I had the opportunity to work as a Policy and Advocacy Intern for Arogya World, and during that time I developed case studies on what works in the prevention of and fight against non-communicable diseases. Four case studies have been completed now, each with a different approach on what are the “best buys” for combating the global NCD pandemic.